HEADER SIGNALING PROTEIN 30-OCT-18 6I1S TITLE CRYSTAL STRUCTURE OF THE ACVR1 (ALK2) KINASE IN COMPLEX WITH FKBP12 TITLE 2 AND THE INHIBITOR E6201 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ACTIVIN RECEPTOR TYPE-1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ACTIVIN RECEPTOR TYPE I,ACTR-I,ACTIVIN RECEPTOR-LIKE KINASE COMPND 5 2,ALK-2,SERINE/THREONINE-PROTEIN KINASE RECEPTOR R1,SKR1,TGF-B COMPND 6 SUPERFAMILY RECEPTOR TYPE I,TSR-I; COMPND 7 EC: 2.7.11.30; COMPND 8 ENGINEERED: YES; COMPND 9 OTHER_DETAILS: STANDARD PEPTIDE PROTEIN CHAIN.; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FKBP1A; COMPND 12 CHAIN: B; COMPND 13 SYNONYM: PPIASE FKBP1A,12 KDA FK506-BINDING PROTEIN,FKBP-12, COMPND 14 CALSTABIN-1,FK506-BINDING PROTEIN 1A,FKBP-1A,IMMUNOPHILIN FKBP12, COMPND 15 ROTAMASE; COMPND 16 EC: 5.2.1.8; COMPND 17 ENGINEERED: YES; COMPND 18 OTHER_DETAILS: STANDARD POLYPETIDE PROTEIN CHAIN. SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ACVR1, ACVRLK2; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_VARIANT: SF9; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 GENE: FKBP1A, FKBP1, FKBP12; SOURCE 15 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 16 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PNIC28-BSA4 KEYWDS KINASE, INHIBITOR, ALK2, ACVR1, FKBP12, COMPLEX, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR E.P.WILLIAMS,D.M.PINKAS,J.FORTIN,J.A.NEWMAN,W.J.BRADSHAW,P.MAHAJAN, AUTHOR 2 K.KUPINSKA,N.BURGESS-BROWN,F.VON DELFT,C.H.ARROWSMITH,A.M.EDWARDS, AUTHOR 3 C.BOUNTRA,A.N.BULLOCK REVDAT 3 24-JAN-24 6I1S 1 REMARK REVDAT 2 25-MAR-20 6I1S 1 JRNL REVDAT 1 11-SEP-19 6I1S 0 JRNL AUTH J.FORTIN,R.TIAN,I.ZARRABI,G.HILL,E.WILLIAMS, JRNL AUTH 2 G.SANCHEZ-DUFFHUES,M.THORIKAY,P.RAMACHANDRAN,R.SIDDAWAY, JRNL AUTH 3 J.F.WONG,A.WU,L.N.APUZZO,J.HAIGHT,A.YOU-TEN,B.E.SNOW, JRNL AUTH 4 A.WAKEHAM,D.J.GOLDHAMER,D.SCHRAMEK,A.N.BULLOCK,P.T.DIJKE, JRNL AUTH 5 C.HAWKINS,T.W.MAK JRNL TITL MUTANT ACVR1 ARRESTS GLIAL CELL DIFFERENTIATION TO DRIVE JRNL TITL 2 TUMORIGENESIS IN PEDIATRIC GLIOMAS. JRNL REF CANCER CELL V. 37 308 2020 JRNL REFN ISSN 1535-6108 JRNL PMID 32142668 JRNL DOI 10.1016/J.CCELL.2020.02.002 REMARK 2 REMARK 2 RESOLUTION. 1.52 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.13-2998 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.52 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.31 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 2.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 85764 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.178 REMARK 3 R VALUE (WORKING SET) : 0.177 REMARK 3 FREE R VALUE : 0.193 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.890 REMARK 3 FREE R VALUE TEST SET COUNT : 4149 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : NULL REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 15.41 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.43 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6I1S COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 30-OCT-18. REMARK 100 THE DEPOSITION ID IS D_1200012645. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-MAY-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9763 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : IMOSFLM 7.2.2 REMARK 200 DATA SCALING SOFTWARE : AIMLESS 7.0.044 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 85856 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.520 REMARK 200 RESOLUTION RANGE LOW (A) : 41.320 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 5.800 REMARK 200 R MERGE (I) : 0.07400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.52 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.55 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 5.80 REMARK 200 R MERGE FOR SHELL (I) : 0.98000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 7.0.044 REMARK 200 STARTING MODEL: 3H9R REMARK 200 REMARK 200 REMARK: CLEAR CRYSTAL. OBLONG. REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.88 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.79 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.05M AMMONIUM SULFATE, 30% REMARK 280 PENTAERYTHRITOL ETHOXYLATE 15/4, 0.1M BIS-TRIS PH 6.5, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.15450 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 57.19450 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 54.29950 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 57.19450 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.15450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 54.29950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3580 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19000 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -20.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 187 REMARK 465 CYS A 188 REMARK 465 THR A 189 REMARK 465 SER A 190 REMARK 465 GLY A 191 REMARK 465 ARG A 273 REMARK 465 HIS A 274 REMARK 465 SER A 275 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MET A 171 CG SD CE REMARK 470 THR A 172 OG1 CG2 REMARK 470 ASP A 185 CG OD1 OD2 REMARK 470 ARG A 218 CD NE CZ NH1 NH2 REMARK 470 GLU A 260 CD OE1 OE2 REMARK 470 SER A 272 OG REMARK 470 SER A 276 OG REMARK 470 GLN A 327 CG CD OE1 NE2 REMARK 470 GLN A 367 CG CD OE1 NE2 REMARK 470 ASN A 421 CG OD1 ND2 REMARK 470 GLN A 480 OE1 NE2 REMARK 470 ASP A 499 CG OD1 OD2 REMARK 470 ARG B 14 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 35 CE NZ REMARK 470 LYS B 45 CG CD CE NZ REMARK 470 LYS B 106 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 701 O HOH A 734 2.09 REMARK 500 O1 SO4 A 510 O HOH A 601 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 211 -54.31 -126.39 REMARK 500 ARG A 335 -3.50 79.10 REMARK 500 ASP A 336 45.65 -143.33 REMARK 500 ASP A 354 86.48 73.90 REMARK 500 ARG B 14 -30.84 -130.58 REMARK 500 ASP B 38 142.63 -171.12 REMARK 500 ALA B 82 -117.45 -125.84 REMARK 500 ILE B 91 -57.96 -132.22 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue E26 A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 505 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 506 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 507 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 508 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 509 REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 510 DBREF 6I1S A 172 499 UNP Q04771 ACVR1_HUMAN 172 499 DBREF 6I1S B 1 108 UNP P62942 FKB1A_HUMAN 1 108 SEQADV 6I1S SER A 170 UNP Q04771 EXPRESSION TAG SEQADV 6I1S MET A 171 UNP Q04771 EXPRESSION TAG SEQADV 6I1S SER B 0 UNP P62942 EXPRESSION TAG SEQRES 1 A 330 SER MET THR THR ASN VAL GLY ASP SER THR LEU ALA ASP SEQRES 2 A 330 LEU LEU ASP HIS SER CYS THR SER GLY SER GLY SER GLY SEQRES 3 A 330 LEU PRO PHE LEU VAL GLN ARG THR VAL ALA ARG GLN ILE SEQRES 4 A 330 THR LEU LEU GLU CYS VAL GLY LYS GLY ARG TYR GLY GLU SEQRES 5 A 330 VAL TRP ARG GLY SER TRP GLN GLY GLU ASN VAL ALA VAL SEQRES 6 A 330 LYS ILE PHE SER SER ARG ASP GLU LYS SER TRP PHE ARG SEQRES 7 A 330 GLU THR GLU LEU TYR ASN THR VAL MET LEU ARG HIS GLU SEQRES 8 A 330 ASN ILE LEU GLY PHE ILE ALA SER ASP MET THR SER ARG SEQRES 9 A 330 HIS SER SER THR GLN LEU TRP LEU ILE THR HIS TYR HIS SEQRES 10 A 330 GLU MET GLY SER LEU TYR ASP TYR LEU GLN LEU THR THR SEQRES 11 A 330 LEU ASP THR VAL SER CYS LEU ARG ILE VAL LEU SER ILE SEQRES 12 A 330 ALA SER GLY LEU ALA HIS LEU HIS ILE GLU ILE PHE GLY SEQRES 13 A 330 THR GLN GLY LYS PRO ALA ILE ALA HIS ARG ASP LEU LYS SEQRES 14 A 330 SER LYS ASN ILE LEU VAL LYS LYS ASN GLY GLN CYS CYS SEQRES 15 A 330 ILE ALA ASP LEU GLY LEU ALA VAL MET HIS SER GLN SER SEQRES 16 A 330 THR ASN GLN LEU ASP VAL GLY ASN ASN PRO ARG VAL GLY SEQRES 17 A 330 THR LYS ARG TYR MET ALA PRO GLU VAL LEU ASP GLU THR SEQRES 18 A 330 ILE GLN VAL ASP CYS PHE ASP SER TYR LYS ARG VAL ASP SEQRES 19 A 330 ILE TRP ALA PHE GLY LEU VAL LEU TRP GLU VAL ALA ARG SEQRES 20 A 330 ARG MET VAL SER ASN GLY ILE VAL GLU ASP TYR LYS PRO SEQRES 21 A 330 PRO PHE TYR ASP VAL VAL PRO ASN ASP PRO SER PHE GLU SEQRES 22 A 330 ASP MET ARG LYS VAL VAL CYS VAL ASP GLN GLN ARG PRO SEQRES 23 A 330 ASN ILE PRO ASN ARG TRP PHE SER ASP PRO THR LEU THR SEQRES 24 A 330 SER LEU ALA LYS LEU MET LYS GLU CYS TRP TYR GLN ASN SEQRES 25 A 330 PRO SER ALA ARG LEU THR ALA LEU ARG ILE LYS LYS THR SEQRES 26 A 330 LEU THR LYS ILE ASP SEQRES 1 B 109 SER MET GLY VAL GLN VAL GLU THR ILE SER PRO GLY ASP SEQRES 2 B 109 GLY ARG THR PHE PRO LYS ARG GLY GLN THR CYS VAL VAL SEQRES 3 B 109 HIS TYR THR GLY MET LEU GLU ASP GLY LYS LYS PHE ASP SEQRES 4 B 109 SER SER ARG ASP ARG ASN LYS PRO PHE LYS PHE MET LEU SEQRES 5 B 109 GLY LYS GLN GLU VAL ILE ARG GLY TRP GLU GLU GLY VAL SEQRES 6 B 109 ALA GLN MET SER VAL GLY GLN ARG ALA LYS LEU THR ILE SEQRES 7 B 109 SER PRO ASP TYR ALA TYR GLY ALA THR GLY HIS PRO GLY SEQRES 8 B 109 ILE ILE PRO PRO HIS ALA THR LEU VAL PHE ASP VAL GLU SEQRES 9 B 109 LEU LEU LYS LEU GLU HET E26 A 501 55 HET EDO A 502 4 HET EDO A 503 4 HET SO4 A 504 5 HET EDO A 505 4 HET EDO A 506 4 HET EDO A 507 4 HET EDO A 508 4 HET EDO A 509 4 HET SO4 A 510 5 HETNAM E26 (4~{S},5~{R},6~{Z},9~{S},10~{S},12~{E})-16- HETNAM 2 E26 (ETHYLAMINO)-4,5-DIMETHYL-9,10,18-TRIS(OXIDANYL)-3- HETNAM 3 E26 OXABICYCLO[12.4.0]OCTADECA-1(14),6,12,15,17-PENTAENE- HETNAM 4 E26 2,8-DIONE HETNAM EDO 1,2-ETHANEDIOL HETNAM SO4 SULFATE ION HETSYN EDO ETHYLENE GLYCOL FORMUL 3 E26 C21 H27 N O6 FORMUL 4 EDO 7(C2 H6 O2) FORMUL 6 SO4 2(O4 S 2-) FORMUL 13 HOH *237(H2 O) HELIX 1 AA1 THR A 179 ASP A 185 1 7 HELIX 2 AA2 PRO A 197 ARG A 206 1 10 HELIX 3 AA3 ASP A 241 VAL A 255 1 15 HELIX 4 AA4 SER A 290 THR A 298 1 9 HELIX 5 AA5 ASP A 301 ILE A 321 1 21 HELIX 6 AA6 LYS A 338 LYS A 340 5 3 HELIX 7 AA7 THR A 378 MET A 382 5 5 HELIX 8 AA8 ALA A 383 ASP A 388 1 6 HELIX 9 AA9 CYS A 395 ARG A 416 1 22 HELIX 10 AB1 SER A 440 CYS A 449 1 10 HELIX 11 AB2 PRO A 458 SER A 463 5 6 HELIX 12 AB3 ASP A 464 TRP A 478 1 15 HELIX 13 AB4 ASN A 481 ARG A 485 5 5 HELIX 14 AB5 THR A 487 LYS A 497 1 11 HELIX 15 AB6 ILE B 57 GLN B 66 1 10 HELIX 16 AB7 PRO B 79 ALA B 82 5 4 SHEET 1 AA1 5 THR A 209 GLY A 217 0 SHEET 2 AA1 5 GLY A 220 TRP A 227 -1 O ARG A 224 N GLU A 212 SHEET 3 AA1 5 GLU A 230 PHE A 237 -1 O ILE A 236 N GLU A 221 SHEET 4 AA1 5 GLN A 278 HIS A 284 -1 O LEU A 281 N LYS A 235 SHEET 5 AA1 5 PHE A 265 THR A 271 -1 N ALA A 267 O ILE A 282 SHEET 1 AA2 3 ALA A 331 ALA A 333 0 SHEET 2 AA2 3 VAL A 359 SER A 362 -1 O HIS A 361 N ALA A 331 SHEET 3 AA2 3 GLN A 367 ASP A 369 -1 O ASP A 369 N MET A 360 SHEET 1 AA3 2 ILE A 342 VAL A 344 0 SHEET 2 AA3 2 CYS A 350 ILE A 352 -1 O CYS A 351 N LEU A 343 SHEET 1 AA4 5 VAL B 3 SER B 9 0 SHEET 2 AA4 5 ARG B 72 ILE B 77 -1 O LYS B 74 N GLU B 6 SHEET 3 AA4 5 LEU B 98 GLU B 108 -1 O PHE B 100 N LEU B 75 SHEET 4 AA4 5 THR B 22 LEU B 31 -1 N THR B 22 O GLU B 108 SHEET 5 AA4 5 LYS B 36 SER B 39 -1 O ASP B 38 N GLY B 29 SHEET 1 AA5 5 VAL B 3 SER B 9 0 SHEET 2 AA5 5 ARG B 72 ILE B 77 -1 O LYS B 74 N GLU B 6 SHEET 3 AA5 5 LEU B 98 GLU B 108 -1 O PHE B 100 N LEU B 75 SHEET 4 AA5 5 THR B 22 LEU B 31 -1 N THR B 22 O GLU B 108 SHEET 5 AA5 5 PHE B 47 MET B 50 -1 O PHE B 49 N CYS B 23 SITE 1 AC1 18 VAL A 214 TYR A 219 ALA A 233 LYS A 235 SITE 2 AC1 18 THR A 283 HIS A 284 TYR A 285 HIS A 286 SITE 3 AC1 18 GLU A 287 GLY A 289 LYS A 340 ASN A 341 SITE 4 AC1 18 LEU A 343 ALA A 353 HOH A 656 HOH A 667 SITE 5 AC1 18 HOH A 674 HOH A 680 SITE 1 AC2 6 PHE A 431 ASP A 433 GLN A 453 ARG A 454 SITE 2 AC2 6 ASN A 456 HOH A 666 SITE 1 AC3 5 ARG A 380 TYR A 432 VAL A 435 PRO A 436 SITE 2 AC3 5 ASN A 437 SITE 1 AC4 5 ARG A 380 ASP A 438 PRO A 439 HOH A 625 SITE 2 AC4 5 HOH A 724 SITE 1 AC5 3 MET A 288 TYR A 294 LEU A 297 SITE 1 AC6 5 TYR A 294 THR A 299 LEU A 300 SER A 304 SITE 2 AC6 5 HOH A 641 SITE 1 AC7 7 ASN A 366 CYS A 395 PHE A 396 ASP A 397 SITE 2 AC7 7 HOH A 639 ILE B 8 PRO B 10 SITE 1 AC8 3 GLY A 217 ARG A 218 HOH A 642 SITE 1 AC9 6 ASP A 397 SER A 398 ARG A 401 PRO A 482 SITE 2 AC9 6 SER A 483 ILE B 8 SITE 1 AD1 8 HIS A 284 HIS A 286 LYS A 345 LYS A 346 SITE 2 AD1 8 HOH A 601 HOH A 626 HOH A 632 HOH A 704 CRYST1 44.309 108.599 114.389 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022569 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009208 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008742 0.00000